Unsere Publikationen

Masanneck L, Räuber S, Schroeter CB, Lehnerer S, Ziemssen T, et al. Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in Germany. DIGITAL HEALTH. 2023;9.
Link
https://doi.org/10.1177/20552076231152989
Tags
Multiple Sklerose
Jahr
2023
Zum Eintrag
Orschiedt J, Jacyshyn-Owen E, Kahn M, Jansen S, Joschko N, Eberl M, Schneeweiss S, Friedrich B, Ziemssen T. The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany. Biomed Pharmacother. 2023 Feb;158:114129.
Link
https://doi.org/10.1016/j.biopha.2022.114129
Tags
Multiple SkleroseMS Behandlung
Jahr
2023
Zum Eintrag
Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen HC, Carruthers R, Edwards KR, Fallis R, Giacomini PS, Greenberg BM, Hafler DA, Ionete C, Kaunzner UW, Lock CB, Longbrake EE, Pardo G, Piehl F, Weber MS, Ziemssen T, Jacobs D, Gelfand JM, Cross AH, Cameron B, Musch B, Winger RC, Jia X, Harp CT, Herman A, ...
Link
https://doi.org/10.1073/pnas.2207291120
Tags
Multiple SkleroseMS BehandlungNeuroimmunologie
Jahr
2023
Zum Eintrag
Ziemssen T, Bhan V, Chataway J, Chitnis T, Campbell Cree BA, Havrdova EK, et al. Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies. Neurol Neuroimmunol Neuroinflamm 2023;10(1).
Link
https://doi.org/10.1212/NXI.0000000000200064
Tags
Multiple Sklerose
Jahr
2023
Zum Eintrag
Ziemssen T, Groth M, Ettle B, Bopp T. Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab. Vaccines (Basel). 2022 Dec 16;10(12):2167.
Link
https://doi.org/10.3390/vaccines10122167
Tags
Multiple SkleroseMS Behandlung
Jahr
2022
Zum Eintrag
Ness N-H, Schriefer D, Haase R, Ziemssen T. The Multiple Sclerosis Health Resource Utilization Survey. Fortschr Neurol Psychiatr 2022;90(1-2):42-48.
Link
https://doi.org/10.1055/a-1471-3636
Tags
Multiple SkleroseManagement & ScienceGesundheitsökonomie
Jahr
2022
Zum Eintrag
Schriefer D, Haase R, Ness N-H, Ziemssen T. Cost of illness in multiple sclerosis by disease characteristics–A review of reviews. Expert Rev Pharmacoecon Outcomes Res 2022;22(2):177-195.
Link
https://doi.org/10.1080/14737167.2022.1987218
Tags
Multiple SkleroseManagement & ScienceGesundheitsökonomie
Jahr
2022
Zum Eintrag
Doose A, Hellerhoff I, Tam FI, King JA, Seidel M, Geisler D, et al. Neural and glial damage markers in women after long-term weight-recovery from anorexia nervosa. Psychoneuroendocrinology 2022;135.
Link
https://doi.org/10.1016/j.psyneuen.2021.105576
Tags
NeuroimmunologieAndere
Jahr
2022
Zum Eintrag

Publikationen durchsuchen

Publikationen filtern

Filter
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Zeige alleVerstecke
Jahr
-